X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs AUROBINDO PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA AUROBINDO PHARMA SANOFI INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 33.3 14.2 234.4% View Chart
P/BV x 6.3 3.6 173.9% View Chart
Dividend Yield % 1.4 0.4 332.4%  

Financials

 SANOFI INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
AUROBINDO PHARMA
Mar-17
SANOFI INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,560895 509.5%   
Low Rs4,400622 707.4%   
Sales per share (Unadj.) Rs1,028.5254.6 404.0%  
Earnings per share (Unadj.) Rs129.039.3 328.3%  
Cash flow per share (Unadj.) Rs186.046.6 399.3%  
Dividends per share (Unadj.) Rs68.002.50 2,720.0%  
Dividend yield (eoy) %1.50.3 460.5%  
Book value per share (Unadj.) Rs753.6160.0 471.1%  
Shares outstanding (eoy) m23.03585.88 3.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.43.0 146.2%   
Avg P/E ratio x34.719.3 179.9%  
P/CF ratio (eoy) x24.116.3 147.9%  
Price / Book Value ratio x5.94.7 125.4%  
Dividend payout %52.76.4 828.4%   
Avg Mkt Cap Rs m103,174444,390 23.2%   
No. of employees `0003.614.0 25.9%   
Total wages/salary Rs m3,59217,678 20.3%   
Avg. sales/employee Rs Th6,537.710,667.8 61.3%   
Avg. wages/employee Rs Th991.41,264.3 78.4%   
Avg. net profit/employee Rs Th819.81,645.8 49.8%   
INCOME DATA
Net Sales Rs m23,686149,157 15.9%  
Other income Rs m7081,159 61.1%   
Total revenues Rs m24,394150,316 16.2%   
Gross profit Rs m5,28134,343 15.4%  
Depreciation Rs m1,3134,276 30.7%   
Interest Rs m15667 2.2%   
Profit before tax Rs m4,66130,558 15.3%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6917,597 22.3%   
Profit after tax Rs m2,97023,012 12.9%  
Gross profit margin %22.323.0 96.8%  
Effective tax rate %36.324.9 145.9%   
Net profit margin %12.515.4 81.3%  
BALANCE SHEET DATA
Current assets Rs m15,67392,062 17.0%   
Current liabilities Rs m6,67866,223 10.1%   
Net working cap to sales %38.017.3 219.2%  
Current ratio x2.31.4 168.8%  
Inventory Days Days76106 71.7%  
Debtors Days Days2268 33.0%  
Net fixed assets Rs m8,09862,919 12.9%   
Share capital Rs m230586 39.3%   
"Free" reserves Rs m17,08893,133 18.3%   
Net worth Rs m17,35693,719 18.5%   
Long term debt Rs m01,814 0.0%   
Total assets Rs m25,400162,494 15.6%  
Interest coverage x311.746.8 666.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 101.6%   
Return on assets %11.814.6 80.6%  
Return on equity %17.124.6 69.7%  
Return on capital %26.932.7 82.3%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,14575,838 9.4%   
Fx outflow Rs m6,84630,224 22.7%   
Net fx Rs m29945,613 0.7%   
CASH FLOW
From Operations Rs m3,22632,786 9.8%  
From Investments Rs m-1,555-17,870 8.7%  
From Financial Activity Rs m-1,818-19,153 9.5%  
Net Cashflow Rs m-147-4,239 3.5%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 8.0 181.1%  
FIIs % 14.6 27.7 52.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 10.2 102.9%  
Shareholders   15,184 69,601 21.8%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 19, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS